Skip Navigation


Cardiovascular Research Advance Access first published online on March 7, 2008
This version [Corrected Proof] published online on April 3, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn061
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
79/2/218    most recent
cvn061v3
cvn061v2
cvn061v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Samuel, J.-L.
Right arrow Articles by Swynghedauw, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Samuel, J.-L.
Right arrow Articles by Swynghedauw, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Genomics in cardiac metabolism

Jane-Lise Samuel1,2, Marcus C. Schaub3, Michael Zaugg4, Mamas Mamas5, Warwick B. Dunn6 and Bernard Swynghedauw1,2,*

1 U689 INSERM, Hôpital Lariboisière, 41 Bd de la Chapelle, 75475 Paris Cedex 10, France
2 Université Denis Diderot, Paris Cedex 7, France
3 Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland
4 Institute of Anaesthesiology, University Hospital Zurich, Zurich, Switzerland
5 Department of Cardiology, Manchester Royal Infirmary, Manchester, UK
6 The Manchester Centre for Integrative Systems Biology, University of Manchester, Manchester, UK

* Corresponding author. Tel: +33 1 5321 6760; fax: +33 1 53 21 67 39. E-mail address: bernard.swynghedauw{at}larib.inserm.fr

Cell biology is in transition from reductionism to a more integrated science. Large-scale analysis of genome structure, gene expression, and metabolites are new technologies available for studying cardiac metabolism in diseases known to modify cardiac function. These technologies have several limitations and this review aims both to assess and take a critical look at some important results obtained in genomics restricted to molecular genetics, transcriptomics and metabolomics of cardiac metabolism in pathophysiological processes known to alter myocardial function. Therefore, our goal was to delineate new signalling pathways and new areas of research from the vast amount of data already published on genomics as applied to cardiac metabolism in diseases such as coronary heart disease, heart failure, and ischaemic reperfusion.

KEYWORDS Cardiac metabolism; Genome-wide analysis; Metabolomics; Transcriptomics

Time for primary review: 15 days

This is a new version as the figure was in black and white in the previous version.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
G. D. Lopaschuk and D. P. Kelly
Signalling in cardiac metabolism
Cardiovasc Res, July 15, 2008; 79(2): 205 - 207.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.